USE OF 6 AMINO-QUINOLINE-5, 8 QUINONES AND NUCLEIC ACIDS ASSOCIATED WITH SENESCENCE FOR THE TREATMENT OF TUMORS

Details for Australian Patent Application No. 2003255504 (hide)

Owner MAX-PLANCK-GESELLSCHAFT ZUR Forderung der Wissenschaften e.V.

Inventors LODYGIN, Dimitri; HERMEKING, Heiko

Pub. Number AU-A-2003255504

PCT Number PCT/EP03/09884

PCT Pub. Number WO2004/022059

Priority 02020087.9 06.09.02 EP

Filing date 5 September 2003

Wipo publication date 29 March 2004

International Classifications

A61K 031/47 - Quinolines

Event Publications

6 November 2003 Complete Application Filed

  Priority application(s): 02020087.9 06.09.02 EP

13 May 2004 Application Open to Public Inspection

  Published as AU-A-2003255504

26 May 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003255505-Antagonists of CXR3-binding CXC chemokines

2003255503-METHOD FOR PRODUCING INVERSE OPALINE STRUCTURES